Clinical Trial Update: A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a recombinant Hepatitis E vaccine conducted in chronic Hepatitis B patients; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Recombinant Hepatitis E Vaccine (Escherichia Coli) (Hepatitis E vaccine (recombinant, E. coli expression))

Snippet

Sponsor: Xiamen Innovax Biotech Co., Ltd | Conditions: Hepatitis E | Phase 4 | Status: COMPLETED | Results posted: 2019-07-25